A Study of Taspoglutide in Type 2 Diabetic Patients

Clinical trial NCT00811460 · COMPLETED

Trial details

NCT number: NCT00811460
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2008-11-01
Primary completion: 2009-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.